Owen Wallace
Chief Tech/Sci/R&D Officer chez MONTE ROSA THERAPEUTICS, INC.
Fortune : 37 125 $ au 31/03/2024
Profil
Owen Wallace is currently the Chief Scientific Officer at Monte Rosa Therapeutics, Inc. Prior to this, he was the Chief Scientific Officer at Fulcrum Therapeutics, Inc. from 2017 to 2021.
He was also the Head-Global Discovery Chemistry at Novartis Institutes for Biomedical Research, Inc. from 2013 to 2017.
From 2002 to 2013, he worked at Eli Lilly & Co. as a Senior Director.
He also worked as a Senior Director-Discovery Chemistry Research at Lilly Research Centre Ltd.
He received his graduate and doctorate degrees from Yale University and his undergraduate degree from University College Cork.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/01/2024 | 5 266 ( 0,01% ) | 37 125 $ | 31/03/2024 |
Postes actifs de Owen Wallace
| Sociétés | Poste | Début |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Anciens postes connus de Owen Wallace
| Sociétés | Poste | Fin |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2021 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2017 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2013 |
| Lilly Research Centre Ltd. | Corporate Officer/Principal | - |
Formation de Owen Wallace
| Yale University | Doctorate Degree |
| University College Cork | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Lilly Research Centre Ltd. |
